Search - tctmd.com

Displaying 201 - 220 of 227

Sort: Relevancy | Date

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

Presentation TCT 2012

Current and Future Clinical Applications of Drug-Coated Balloons: From Bench to Bedside

Presenter: Bruno Scheller

October 26, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation TCT 2012

Drug-Coated Balloons and Atherectomy: Additive, Synergistic, or Without Advantage?

Presenter: Luigi Salemme

October 22, 2012

News Industry News

Vascular Nanotransfer Technologies (“VNT”) reports in vivo results for its paclitaxel nano-carrier based drug coated balloon (DCB) technology

October 19, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Industry News

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

July 03, 2012

News Industry News

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

May 16, 2012

News Industry News

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

April 13, 2012

News Daily News

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

Jason Kahn

March 22, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

Presentation ISET 2012

Drug-coated Balloons and Stents in the Periphery: Is There a Future?

Presenter: Ron Waksman

January 15, 2012

News Industry News

Bard Acquires Lutonix, Inc.

December 19, 2011

News Conference News

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

November 27, 2011

News Conference News

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

November 17, 2011

News Industry News

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

November 09, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

Advertisement

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Current and Future Clinical Applications of Drug-Coated Balloons: From Bench to Bedside

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Drug-Coated Balloons and Atherectomy: Additive, Synergistic, or Without Advantage?

Vascular Nanotransfer Technologies (“VNT”) reports in vivo results for its paclitaxel nano-carrier based drug coated balloon (DCB) technology

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

Cardionovum® begins in vivo testing of its paclitaxel-coated RESTORE® drug-eluting balloon (DEB), designed to increase drug-in-tissue concentration

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Drug-coated Balloons and Stents in the Periphery: Is There a Future?

Bard Acquires Lutonix, Inc.

PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis

Drug-Eluting Balloons an Option for Patients with BMS Restenosis, High Bleeding Risk

Bayer HealthCare's Cotavance Drug Eluting Balloon With Paccocath Technology Reduced Five-Year Target Lesion Revascularization Rates

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content